DV
Dividend Vision

COCP — Cocrystal Pharma Inc

Cocrystal Pharma Inc (COCP)

Total return is 39900.0% over the past 18.4 years, 39206.0 points ahead of SPY at 694.0%. Its deepest 1-year drawdown was 51.8%.

COCP is an equity stock that focuses on the pharmaceutical sector. The fund does not currently distribute dividends, making it unsuitable for income-focused investors seeking regular payouts. This holding appeals primarily to growth-oriented investors interested in exposure to the biotechnology and pharmaceutical industry rather than dividend income strategies.

COCP key facts

Asset type
Stock
Asset class
Equity
Inception date
04/01/2008
Last close
$1.12
Market cap
$13,098,080
Average volume
38298.0
Payment date
01/24/2018
Beta
1.407
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.72